In vitro mimicry of in vivo KPC mutations by ceftazidime-avibactam: phenotypes, mechanisms, genetic structure and kinetics of enzymatic hydrolysis
Ceftazidime-avibactam (CZA) is employed for the treatment of infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP). Resistance to CZA is frequently linked to point mutations in the blaKPC. We conducted in vitro simulations of in vivo blaKPC mutations using CZA. Fo...
שמור ב:
| Principais autores: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2024-12-01
|
| סדרה: | Emerging Microbes and Infections |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/22221751.2024.2356146 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
